Home » Stocks » CCEL

Cryo-Cell International Inc. (CCEL)

Stock Price: $9.45 USD -0.05 (-0.53%)
Updated Jul 23, 2021 12:46 PM EDT - Market closed
Market Cap 79.81M
Revenue (ttm) 29.72M
Net Income (ttm) 3.85M
Shares Out 7.96M
EPS (ttm) 0.48
PE Ratio 19.69
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 23
Last Price $9.45
Previous Close $9.50
Change ($) -0.05
Change (%) -0.53%
Day's Open 9.20
Day's Range 9.20 - 9.45
Day's Volume 419
52-Week Range 6.45 - 10.10

News

Hide News

OLDSMAR, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem c...

1 week ago - GlobeNewsWire

MIAMI, May 10, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell's Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine are c...

2 months ago - GlobeNewsWire

OLDSMAR, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ...

3 months ago - GlobeNewsWire

About CCEL

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to p... [Read more...]

Industry
Medical Care Facilities
IPO Date
Jan 21, 1997
Stock Exchange
OTCMKTS
Ticker Symbol
CCEL
Full Company Profile

Financial Performance

In 2020, CCEL's revenue was $31.15 million, a decrease of -2.10% compared to the previous year's $31.82 million. Earnings were $3.62 million, an increase of 58.23%.

Financial Statements